Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Hormone replacement therapy and cardiovascular health in the United States.

Shetty KD, Vogt WB, Bhattacharya J.

Med Care. 2009 May;47(5):600-6. doi: 10.1097/MLR.0b013e31818bfe9b.

PMID:
19319001
2.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
3.

[Cardiovascular risk and hormone replacement therapy in menopause].

Plu-Bureau G.

Therapie. 1999 May-Jun;54(3):375-80. Review. French.

PMID:
10500454
4.

The risk of stroke in postmenopausal women receiving hormonal therapy.

Lobo RA.

Climacteric. 2009;12 Suppl 1:81-5. Review.

PMID:
19811248
5.

Hormone replacement therapy in postmenopausal women.

Staren ED, Omer S.

Am J Surg. 2004 Aug;188(2):136-49. Review.

PMID:
15249239
6.

Postmenopausal hormone therapy and the risk of cardiovascular disease.

Stramba-Badiale M.

J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):303-9. doi: 10.2459/JCM.0b013e328324991c. Review.

PMID:
19430340
7.

Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.

Abramson BL.

J Cardiovasc Risk. 2002 Dec;9(6):309-14. Review.

PMID:
12478199
9.
10.

Benefits of hormone replacement therapy in postmenopausal women.

Canderelli R, Leccesse LA, Miller NL, Unruh Davidson J.

J Am Acad Nurse Pract. 2007 Dec;19(12):635-41. Review.

PMID:
18042129
11.

The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.

Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M.

Maturitas. 2009 Oct 20;64(2):80-5. doi: 10.1016/j.maturitas.2009.07.015. Epub 2009 Aug 25. Review.

PMID:
19709827
12.

Hormone replacement therapy and cardiovascular risk.

Chong AY, Lip GY.

Treat Endocrinol. 2002;1(2):95-103. Review.

PMID:
15765625
13.

Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.

Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C.

J Endocrinol Invest. 2005;28(10 Suppl):80-4. Review.

PMID:
16550729
14.

Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?

Rosano GM, Vitale C, Fini M.

Ann N Y Acad Sci. 2006 Dec;1092:341-8. Review.

PMID:
17308159
15.

[Postmenopausal hormone therapy and vascular risk].

Lamy C.

Rev Neurol (Paris). 2007 Sep;163(8-9):851-6. Review. French.

PMID:
17878815
16.

Hormone replacement therapy: prothrombotic vs. protective effects.

Lowe GD.

Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):329-32. Review.

PMID:
14509584
17.

Hormone replacement therapy: controversies, pros and cons.

Warren MP, Halpert S.

Best Pract Res Clin Endocrinol Metab. 2004 Sep;18(3):317-32. Review.

PMID:
15261840
18.

Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.

Koledova VV, Khalil RA.

Expert Rev Cardiovasc Ther. 2007 Jul;5(4):777-89. Review.

PMID:
17605655
19.

Hormone replacement therapy--is there a place for its use in neurology?

Vuković V, Lovrencić-Huzjan A, Solter VV, Dordević V, Demarin V.

Coll Antropol. 2003 Jun;27(1):413-24. Review.

PMID:
12974172
20.

HRT and cardiovascular disease.

Meade TW, Vickers MR.

J Epidemiol Biostat. 1999;4(3):165-90. Review.

PMID:
10695958

Supplemental Content

Support Center